Crossmark

Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients

Crossref DOI link: https://doi.org/10.1007/s00432-019-03008-9

Published Online: 2019-08-24

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cabanillas Stanchi, Karin Melanie

Queudeville, Manon

Malaval, Carmen

Feucht, Judith

Schlegel, Patrick

Dobratz, Markus

Seitz, Christian

Müller, Ingo

Lang, Peter

Handgretinger, Rupert

Döring, Michaela http://orcid.org/0000-0002-8134-7350
Funding

Funding for this research was provided by:

Stefan-Morsch-Stiftung, Birkenfeld, Germany (-)

Bettina-Bräu-Stiftung, Fürstenfeldbruck, Germany (-)
License Information

Text and Data Mining valid from 2019-08-24

Version of Record valid from 2019-08-24
More Information

Article History

Received: 24 April 2019

Accepted: 19 August 2019

First Online: 24 August 2019

Compliance with ethical standard

:

: The authors declare that they have no conflicts of interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Document is current

Any future updates will be listed below